Accepted for/Published in: JMIRx Med
Date Submitted: Jun 7, 2021
Open Peer Review Period: Jun 7, 2021 - Aug 2, 2021
Date Accepted: Jan 27, 2022
Date Submitted to PubMed: Aug 4, 2023
(closed for review but you can still tweet)
Left Ventricular Outflow Tract Obstruction in patients treated with Milrinone for Cerebral Vasospasm
ABSTRACT
Subarachnoid hemorrhage is associated with a high morbidity and mortality, and cerebral arterial vasospasm is one of its main complications that determines neurological prognosis. The use of intravenous milrinone is becoming more and more common in the treatment of vasospasm. This molecule has positive inotropic and vasodilating properties by inhibiting phosphodiesterase-3. Its most described side effects are cardiac arrhythmias and arterial hypotension. In this work, we raise new issue concerning milrinone and discuss an undescribed side effect of this treatment, the left ventricular outflow tract obstruction (LVOTO). LVOTO is a clinical situation favored by hypovolemia, decreased left ventricular afterload and excessive inotropism that can lead to severe hemodynamic failure and pulmonary edema. To our knowledge, this is the first work describing milrinone-induced LVOTO. This could compromise cerebral perfusion, and therefore the neurological prognosis of patients. While it is known that catecholamines may induce LVOTO, milrinone-induced LVOTO appears to be a new pathophysiological entity of which neurosurgical intensivists should be aware.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.